Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy

Clinical trial NCT01220609 · COMPLETED

Trial details

NCT number: NCT01220609
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Uterine Corpus Sarcoma Uterine Corpus Leiomyosarcoma

Start date: 2010-11-01
Primary completion: 2014-07-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.